MedCity News June 13, 2024
Marissa Plescia

There is a shortage of GLP-1s in the U.S. But experts have differing opinions on whose responsibility it is to be rationing the drugs.

GLP-1s have proven to be effective in weight loss, but the nation is grappling with shortages and high costs of the drugs. So who should be making the call on which patients get access to the drugs?

According to Dr. Timothy Law, chief medical officer of Highmark, physicians should be the decision-makers, and insurers should be “conduits to care, not roadblocks.”

“We need to get out of the way of the physician and let them do their job. … [Physicians] who are seeing patients on a regular basis need to be the ones that do the...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Conferences / Podcast, Insurance, Patient / Consumer, Payer, Pharma / Biotech, Provider, Trends
Health Economics and Outcomes Research: Biopharma’s Underappreciated Value Creator
BridgeBio Oncology to Go Public in SPAC Deal Bringing $450M+ for Trio of Cancer Drugs
Rare Disease Biotech Zevra Therapeutics to Sell FDA Drug Review Fast Pass for $150M
AI Accelerates Discovery of Genes Linked to Neurodevelopmental Disorders
A new era of Made in America drug manufacturing

Share This Article